Ragusa M, Barbagallo C, Statello L, Condorelli AG, Battaglia R, Tamburello L, Barbagallo D, Di Pietro C, Purrello M: Non-coding landscapes of colorectal cancer. World J Gastroenterol 2015, 21:11709-11739.
Ma Y, Liang AJ, Fan YP, Huang YR, Zhao XM, Sun Y, Chen XF: Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis. Oncotarget 2016, 7:42805-42825.
Slattery ML, Herrick JS, Pellatt DF, Mullany LE, Stevens JR, Wolff E, Hoffman MD, Wolff RK, Samowitz W: Site-specific associations between miRNA expression and survival in colorectal cancer cases. Oncotarget 2016, 7:60193-60205.
Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, Hansen U, Brunner N, Baker A, Moller S, Nielsen HJ: High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 2011, 28:27-38.
Carter JV, Galbraith NJ, Yang D, Burton JF, Walker SP, Galandiuk S: Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Br J Cancer 2017, 116:762-774.
Akcakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H, Lui WO: miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol 2011, 39:311-318.
Aherne ST, Madden SF, Hughes DJ, Pardini B, Naccarati A, Levy M, Vodicka P, Neary P, Dowling P, Clynes M: Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression. BMC Cancer 2015, 15:329.
Zhang GJ, Zhou H, Xiao HX, Li Y, Zhou T: MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. BMC Cancer 2014, 14:109.
Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY: Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 2010, 25:1674-1680.
Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A: Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. Clin Chem Lab Med 2014, 52:1217-1227.
Yuan D, Li K, Zhu K, Yan R, Dang C: Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Cancer Biol Ther 2015, 16:268-275.
Li J, Liu Y, Wang C, Deng T, Liang H, Wang Y, Huang D, Fan Q, Wang X, Ning T, et al: Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma. Sci Rep 2015, 5:12921.
Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A: Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. J Natl Cancer Inst 2015, 107.
Chen J, Wang W, Zhang Y, Chen Y, Hu T: Predicting distant metastasis and chemoresistance using plasma miRNAs. Med Oncol 2014, 31:799.
Liu K, Li G, Fan C, Zhou X, Wu B, Li J: Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer. J Int Med Res 2011, 39:2288-2295.
Perez-Carbonell L, Sinicrope FA, Alberts SR, Oberg AL, Balaguer F, Castells A, Boland CR, Goel A: MiR-320e is a novel prognostic biomarker in colorectal cancer. Br J Cancer 2015, 113:83-90.
Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, Liu W, Qin H: miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut 2012, 61:1447-1453.
Karaayvaz M, Zhai H, Ju J: miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death Dis 2013, 4:e659.
Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, et al: Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 2013, 14:589.
Perilli L, Vicentini C, Agostini M, Pizzini S, Pizzi M, D'Angelo E, Bortoluzzi S, Mandruzzato S, Mammano E, Rugge M, et al: Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression. Oncotarget 2014, 5:6611-6619.
Grassi A, Perilli L, Albertoni L, Tessarollo S, Mescoli C, Urso EDL, Fassan M, Rugge M, Zanovello P: A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer. In Mol Cancer. Volume 17. England2018: 17
Wei Q, Lei R, Hu G: Roles of miR-182 in sensory organ development and cancer. Thorac Cancer 2015, 6:2-9.
Zhang Y, Wang X, Wang Z, Tang H, Fan H, Guo Q: miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer. Oncol Rep 2015, 33:2592-2598.
Yang MH, Yu J, Jiang DM, Li WL, Wang S, Ding YQ: microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis. J Transl Med 2014, 12:109.
Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI: MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia 2012, 14:868-879.
Dalerba P, Guiducci C, Poliani PL, Cifola I, Parenza M, Frattini M, Gallino G, Carnevali I, Di Giulio I, Andreola S, et al: Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. Cancer Res 2005, 65:2321-2329.
Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L, Reboldi A, Favaro E, Mecarozzi M, Di Mario G, et al: Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. Cancer Res 2009, 69:1314-1323.
Serafin V, Persano L, Moserle L, Esposito G, Ghisi M, Curtarello M, Bonanno L, Masiero M, Ribatti D, Sturzl M, et al: Notch3 signalling promotes tumour growth in colorectal cancer. J Pathol 2011, 224:448-460.
Pasto A, Serafin V, Pilotto G, Lago C, Bellio C, Trusolino L, Bertotti A, Hoey T, Plateroti M, Esposito G, et al: NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells. Cancer Res 2014, 74:2106-2118.
affyQCReport: QC Report Generation for affyBatch objects. R package version 1.48.0
Gautier L, Cope L, Bolstad BM, Irizarry RA: affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20:307-315.
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015, 43:e47.
Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al: miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res 2016, 44:D239-247.
Agarwal V, Bell GW, Nam JW, Bartel DP: Predicting effective microRNA target sites in mammalian mRNAs. Elife 2015, 4.
Erol A: Deciphering the intricate regulatory mechanisms for the cellular choice between cell repair, apoptosis or senescence in response to damaging signals. Cell Signal 2011, 23:1076-1081.
Krishnan K, Steptoe AL, Martin HC, Wani S, Nones K, Waddell N, Mariasegaram M, Simpson PT, Lakhani SR, Gabrielli B, et al: MicroRNA-182-5p targets a network of genes involved in DNA repair. Rna 2013, 19:230-242.
Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L: Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Mol Carcinog 2017, 56:2669-2680.
Jia L, Luo S, Ren X, Li Y, Hu J, Liu B, Zhao L, Shan Y, Zhou H: miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway. Dig Dis Sci 2017, 62:3447-3459.
Salvador JM, Brown-Clay JD, Fornace AJ, Jr.: Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol 2013, 793:1-19.
Li X, Tian R, Gao H, Yang Y, Williams BRG, Gantier MP, McMillan NAJ, Xu D, Hu Y, Gao Y: Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients. Sci Rep 2017, 7:16495.
Huang J, Gong Z, Ghosal G, Chen J: SOSS complexes participate in the maintenance of genomic stability. Mol Cell 2009, 35:384-393.